Status:
ACTIVE_NOT_RECRUITING
Treatment of Orthostatic Intolerance
Lead Sponsor:
Satish R. Raj
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Tachycardia
Chronic Orthostatic Intolerance
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic in...
Detailed Description
This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic in...
Eligibility Criteria
Inclusion
- Chronic symptoms (\> 6 months) with standing upright
Exclusion
- Obvious cause of hypovolemia or drugs that could worsen tachycardia
- Chronic severe medical conditions such as cancer or ischemic heart disease
Key Trial Info
Start Date :
April 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2029
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00262470
Start Date
April 1 1997
End Date
December 1 2029
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Autonomic Dysfunction Center
Nashville, Tennessee, United States, 37232-2195